DUBLIN--(BUSINESS WIRE)--

Research and Markets (http://www.researchandmarkets.com/research/c4ea42/biotechnology_gl) has announced the addition of the "Biotechnology - Global Outlook" report to their offering.

The global outlook series on Biotechnology provides a collection of statistical anecdotes, market briefs, and concise summaries of research findings. The report offers a bird's eye view of the Biotechnology industry. Annotated with 21 fact, and data rich tables the report offers a sneak peek into major end-use industries. Also included is a compilation of all recent mergers, acquisitions, and strategic corporate developments. A regional-level of discussion mirrors the prevalent scenario in key regional markets such as the US, Canada, Mexico, Japan, France, Germany, Poland, UK, Sweden, Switzerland, New Zealand, India, Malaysia, and Brazil, among few others.

Companies mentioned include Abbott, Amgen, AstraZeneca, Biogen Idec, Elan, GlaxoSmithKline, Johnson & Johnson, Lexicon Genetics, MedImmune, Novartis, Novo Nordisk, OSI Pharmaceuticals, Pfizer, Sanofi-Aventis, and many others.

Key Topics Covered:

For more information, including full table of contents, please visit http://www.researchandmarkets.com/research/c4ea42/biotechnology_gl

Read more:
Research and Markets: Biotechnology - Global Outlook